Metraipolis › archive › dc_eaa885e48848

Prognostic value of platelet to lymphocyte ratio (PLR) in breast cancer patients receiving neoadjuvant therapy: a systematic review and meta-analysis — Europe PMC PMID:40909265

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40909265
DOI
10.3389/fimmu.2025.1658571
License (as archived)
solo-consultazione
Archived
2026-11-10T11:47:08.861Z
SHA-256 of the archived text
09b92a9932c8565c172167becfd57d49c9fc81ce728ec992ba708e7f08468c5a
Stable URL of this page
https://metraipolis.com/documento/dc_eaa885e48848

How to cite

Prognostic value of platelet to lymphocyte ratio (PLR) in breast cancer patients receiving neoadjuvant therapy: a systematic review and meta-analysis — Europe PMC PMID:40909265 — Europe PMC (en), https://europepmc.org/article/MED/40909265 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_eaa885e48848 (Metraipolis archive dc_eaa885e48848, sha256 09b92a9932c8565c172167becfd57d49c9fc81ce728ec992ba708e7f08468c5a)
BibTeX
@misc{dceaa885e48848,
  title = {Prognostic value of platelet to lymphocyte ratio (PLR) in breast cancer patients receiving neoadjuvant therapy: a systematic review and meta-analysis — Europe PMC PMID:40909265},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40909265},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_eaa885e48848; sha256 09b92a9932c8565c172167becfd57d49c9fc81ce728ec992ba708e7f08468c5a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40909265. Agents can read the archived copy with the MCP tool read_document.